The Pharmaceutical Journal
Vol 271 No 7278 p794
6 December 2003

Society summary

Nine pharmacists designated as fellows of the Society

The Royal Pharmaceutical Society's panel of fellows has designated the following nine pharmacists fellows of the Society: Professor Martyn Davies, Sue Faulding, Stephen Lutener, Dr Kay Marshall, Andrew Radley, Jeremy Savage, Peter Sharott, Bob Shaw and John Turner.

The following brief biographical information is based on material provided by the panel to assist in identifying the pharmacists concerned. It does not necessarily represent the reasons for their designation as fellows.

Professor Martyn Davies is an academic pharmacist who registered in 1981. Since 1996 he has been professor of biomedical surface chemistry at the University of Manchester and since 2000 also head of the university’s school of pharmaceutical sciences and pharmacy school. He joined the university’s staff in 1984 as a temporary lecturer and from 1985 to 1991 was a lecturer in drug delivery. He was this year made a fellow of the Royal Society of Chemistry and a fellow of the American Institute for Medical and Biological Engineering.

Sue Faulding, who registered in 1979, is pharmaceutical adviser in the National Prescribing Centre’s Prescribing Support Unit, which is based in Leeds. Previously, from 1998 to 2001, she was senior pharmaceutical adviser to Leeds Health Authority, following two-and-a-half years as principal pharmaceutical officer in the NHS Executive prescribing branch. Since 1998 she has been a member of the UK Drug Usage Review Group. She is a former chairman of the Society’s West Metropolitan branch (1989–91) and Leeds branch (1998–2000).

Stephen Lutener, who registered in 1980, has recently left the staff of the Society after 16 years involved with professional standards. He had served as a professional standards inspector (1987–89), a pharmacist adviser (1989–91), head of professional ethics (1991–92), head of pharmacy law (1992–2001) and joint acting director of professional standards (2001–03).

Dr Kay Marshall is an academic pharmacist who registered in 1981. She was appointed a senior lecturer in pharmacology in the University of Bradford’s school of pharmacy in 1997. She led the school’s subject review team in 1998–2000 and established Bradford’s intercalated degree with Leeds Medical School in 2001. She leads 10 undergraduate modules. She was a topic expert in the production of the Centre for Pharmacy Postgraduate Education learning programme to support over-the-counter availability of emergency hormonal contraception and is co-author of the CPPE workshop on “Women’s health”.

Andrew Radley is a hospital pharmacist who registered in 1986. He has been principal pharmacist for area patient services for NHS Tayside since 2000, after six years as clinical director of pharmacy for Perth and Kinross Healthcare NHS Trust. He was awarded a Sir Hugh Linstead research fellowship by the Society in 1995.

Jeremy Savage, who registered in 1982, is chief pharmacist and clinical director at West Wales General Hospital, Carmarthen. He has served on the Welsh Pharmaceutical Committee since 1991 and has chaired it since 2000. He has been a member of the Welsh Chief Pharmacists’ Committee since 1993 and vice-chairman and treasurer since 2001. He has represented Wales on the Society’s Hospital Pharmacists Group Committee since 2000. He has been chairman of the Dyfed/Powys Health Authority multiprofessional advisory group since 2000. He is a member of the NHS Industry Forum of the All Wales Medicines Strategy Group.

Peter Sharott, who registered in 1971, is a pharmaceutical adviser to the Directorate of Health and Social Care for London and to London, Eastern and South East Specialist Pharmacy Services. He is chairman of the Pharmaceutical Market Support Group. He is the Society’s representative on the professional advisory panel of the NHS Litigation Authority and a member of the Cabinet Office advisory panel on “Cutting red tape for frontline hospital staff”.

Bob Shaw, who registered in 1972, was recently appointed the first director of undergraduate studies for pharmacy in the school of chemical sciences and pharmacy at the University of East Anglia. He was formerly director of the NHS academic pharmacy practice unit based at the university and NHS regional specialist in pharmaceutical quality assurance. In 2002 he was appointed chairman of the NHS Pharmaceutical Quality Assurance Strategy Group and the NHS Pharmaceutical Quality Assurance Committee, and also became a member of the good manufacturing practice/good dispensing practice consultative committee. He received the Abbot Laboratories award of the Guild of Hospital Pharmacists in 1990.

John Turner, who registered in 1965, was one of the first UK medicines inspectors when the Medicines Act 1968 was implemented. He contributed to the development of the first national guide to good manufacturing practice for pharmaceuticals in the 1970s and the establishment of the UK medicines inspectorate. He has been involved in the development of the pharmaceutical inspections system in the UK and European Community, playing a leading personal role in a number of key international committees and working groups. He also played a leading role in developing and maintaining the qualified person scheme in the UK.

Official Notice, p798